Conventional and multicolor FICTION as tools for the interdisciplinar study of hematological neoplasms;FICTION convencional y multicolor como herramientas para el estudio interdisciplinar de las neoplasias hematológicas

Anales del Sistema Sanitario de Navarra

Volumn 25, Issue 3, 2002, Pages 289-304

  Martin Subero I ^a   Siebert, R ^a   Calasanz, M J ^b  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b NONE

Author keywords

FICTION; Hematological neoplasms; Multicolor labeling

Indexed keywords

ADOLESCENT; ADULT; BLOOD DISEASE; CASE REPORT; CELL STRUCTURE; CHROMOSOME ABERRATION; COLOR; CYTOGENETICS; FLUORESCENCE; GENETIC MARKER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; LABELING INDEX; REVIEW; TECHNOLOGY; TUMOR CELL;

EID: 0036767697     PISSN: 11376627     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (53)

1. The non-Hodgkin's lymphoma classification project. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project. Cancer 1982; 49: 2112-2135.
2. LENNERT K, STEIN H, KAISERLING E. Cytological and functional criteria for the classification of malignant lymphomata. Br J Cancer 1975; 31: 29-43.
3. JAFFE ES. Hematopathology: integration of morphologic features and biologic markers for diagnosis. Mod Pathol 1999; 12: 109-115.
4. HARRIS NL, JAFFE ES, VARDIMAN JW, STEIN H, DIEBOLD J, MÜLLER-HERMELINK HK et al. WHO classification of haematopoietic and lymphoid tissues: Introduction. En: Jaffe E S, Harris N L, Stein H, Vardiman J W, editores. World Health Organization classification of tumours. Pathology and genetics of tumours of haemopoietic and lymphoid tissues. Lion (Francia): IARC, 2001: 12-13.
5. HARRIS NL, JAFFE ES, DIEBOLD J, FLANDRIN G, MULLER-HERMELINK HK, VARDIMAN J et al. The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting - Airlie House, Virginia, November, 1997. Hematol J 2000; 1: 53-66.
6. LINDBLOM A, LILJEGREN A. Regular review: tumour markers in malignancies. Br Med J 2000; 320: 424-427.
7. NOWELL PC, ROWLEY JD, KNUDSON AG. Cancer genetics, cytogenetics - defining the enemy within. Nat Med 1998; 4: 1107-1111.
8. WEBER-MATTHIESEN K, WINKEMANN M, MÜLLERHERMELINK A, SCHLEGELBERGER B, GROTE W. Simultaneous fluorescence immunophenotyping and interphase cytogenetics: a contribution to the characterization of tumor cells. J Histochem Cytochem 1992, 40: 171-175.
9. WHITE DL, HUTCHINS CJ, HAYLOCK DN, TURCZYNOWICZ S, BISHOP A, TO LB et al. Direct analysis of FACS-sorted hemopoietic cell fractions using FISH. Biotechniques 1995; 18: 820-821.
10. TEERENHOVI L, KNUUTILA S, EKBLOM M, Rossi L, BORGSTROM GH, TALLMAN JK et al. A method for simultaneous study of the karyotype, morphology, and immunologic phenotype of mitotic cells in hematologic malignancies. Blood 1984; 64: 1116-1622.
11. GARCIA-MARCO J, MATUTES E, MORILLA R, ELLIS J, OSCIER D, FANTES J et al. Trisomy 12 in B-cell chronic lymphocytic leukaemia: assessment of lineage restriction by simultaneous analysis of immunophenotype and genotype in interphase cells by fluorescence in situ hybridization. Br J Haematol 1994; 87: 44-50.
12. GAHN B, SCHAFER C, NEEF J, TROFF C, FEURINGBUSKE M, HIDDEMANN W et al. Detection of trisomy 12 and Rb-deletion in CD34+ cells of patients with B-cell chronic lymphocytic leukemia. Blood 1997; 89: 4275-4281.
13. GAHN B, WENDENBURG B, TROFF C, NEEF J, GROVE D, HAFERLACH T et al. Analysis of progenitor cell involvement in B-CLL by simultaneous immunophenotypic and genotypic analysis at the single cell level. Br J Haematol 1999; 105: 955-959.
14. KNUUTILA S. Immunophenotyping and molecular cytogenetics. J Histochem Cytochem 1992; 40: 1427.
15. WEBER-MATTHIESEN. Immunophenotyping and molecular cytogenetics. Author's response. J Histochem Cytochem 1992; 40: 1428.
16. GOZZETTI A, LE BEAU MM. Fluorescence in situ hybridization: uses and limitations. Semin Hematol 2000; 37: 320-333.
17. CALASANZ MJ. Revisión de técnicas de citogenética convencional y molecular y su implicación en el diagnóstico y pronóstico del cáncer. ANALES Sis San Navarra 2001; 24: 17-29.
18. MARTIN-SUBERO JI, GESK S, HARDER L, GROTE W, SIEBERT R. Interphase cytogenetics of hematological neoplasms under the perspective of the novel WHO classification. Anticancer Res. (En prensa).
19. KEARNEY L. The impact of the new fish technologies on the cytogenetics of haematological malignancies. Br J Haematol 1999; 104: 648-658.
20. WEBER-MATTHIESEN K, MULLER-HERMELINK A, DEERBERG J, SCHERTHAN H, SCHLEGELBERGER B, GROTE W. Discrimination of distinct subpopulations within a tumor with combined double immunophenotyping and interphase cytogenetics. J Histochem Cytochem 1993; 41: 1641-1644.
21. WEBER-MATTHIESEN K, PRESSL S, SCHLEGELBERGER B, GROTE W. Combined immunophenotyping and interphase cytogenetics on cryostat sections by the new FICTION method. Leukemia 1993; 7: 646-649.
22. SCHLEGELBERGER B, METZKE S, HARDER S, ZÜHLKEJENISCH R, ZHANG Y, SIEBERT R. Classical and molecular cytogenetics of tumor cells. En: Wegner R, editor. Diagnostic cytogenetics. Nueva York: Springer-Verlag, 1999: 151-185.
23. BRUNNING RD, MATUTES E, FLANDRIN G, VARDIMAN J, BENNET J, HEAD D et al. Acute myeloid leukaemia with recurrent genetic abnormalities. En: Jaffe E S, Harris N L, Stein H, Vardiman J W, editores. World Health Organization classification of tumours. Pathology and genetics of tumours of haemopoietic and lymphoid tissues. Lion (Francia): IARC, 2001: 81-87.
24. KNUUTILA S, TEERENHOVI L, LARRAMENDY ML, ELONEN E, FRANSSILA KO, NYLUND SJ et al. Cell lineage involvement of recurrent chromosomal abnormalities in hematologic neoplasms. Genes Chromosomes Cancer 1994; 10: 95-102.
25. GARCÍA-MARCO JA, PRICE CM, ELLIS J, MOREY M, MATUTES E, LENS D et al. Correlation of trisomy 12 with proliferating cells by combined immunocytochemistry and fluorescence in situ hybridization in chronic lymphocytic leukemia. Leukemia 1996; 10: 1705-1711.
26. ZANDECKI M, LAI JL, GENEVIEVE F, BERNARDI F, VOLLE-REMY H, BLANCHET O et al. Several cytogenetic subclones may be identified within plasma cells from patients with monoclonal gammopathy of undetermined significance, both at diagnosis and during the indolent course of this condition. Blood 1997; 90: 3682-3690.
27. HARRIS NL. Hodgkin's disease: classification and differential diagnosis. Mod Pathol 1999; 12: 159-175.
28. WEBER-MATTHIESEN K, DEERBERG J, POETSCH M, GROTE W, SCHLEGELBERGER B. Numerical chromosome aberrations are present within the CD30+ Hodgkin and Reed-Sternberg cells in 100% of analyzed cases of Hodgkin's disease. Blood 1995; 86: 1464-1468.
29. SIEBERT R, ROSENWALD A, STAUDT LM, MORRIS SW. Molecular features of B-cell lymphoma. Curr Opin Oncol 2001; 13: 316-324.
30. WILLIS TG, DYER MJ. The role of immunoglobulin translocations in the pathogenesis of B-cell malignancies. Blood 2000; 96: 808-822.
31. WEBER-MATTHIESEN K, DEERBERG-WITTRAM J, ROSENWALD A, POETSCH M, GROTE W, SCHLEGELBERGER B. Translocation t(2;5) is not a primary event in Hodgkin's disease. Simultaneous immunophenotyping and interphase cytogenetics. Am J Pathol 1996; 149: 463-468.
32. TRÜMPER L, PFREUNDSCHUH M, BONIN FV, DAUS H. Detection of the t(2;5)-associated NPM/ALK fusion cDNA in peripheral blood cells of healthy individuals. Br J Haematol 1998; 103: 1138-1144.
33. KALLIONIEMI A, KALLIONIEMI OP, SUDAR D, RUTOVITZ D, GRAY JW, WALDMAN F et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992; 258: 818-821.
34. ZUDAIRE MI, ODERO MD, CABALLERO MC, VALENTI C, MARTÍNEZ-PEÑUELA JM, CALASANZ MJ. Identificación de nuevos marcadores citogenéticos con valor pronóstico en cáncer de mama. Anales Sis San Navarra 2001; 24: 25-37.
35. KUUKASJARVI T, TANNER M, PENNANEN S, KARHU R, VISAKORPI T, ISOLA J. Optimizing DOP-PCR for universal amplification of small DNA samples in comparative genomic hybridization. Genes Chromosomes Cancer 1997; 18: 94-101.
36. JOOS S, MENZ CK, WROBEL G, SIEBERT R, GESK S, OHL S et al. Classical Hodgkin lymphoma is characterized by recurrent copy number gains of the short arm of chromosome 2. Blood 2002; 99: 1381-1387.
37. BARGOU RC, LENG C, KRAPPMANN D, EMMERICH F, MAPARA MY, BOMMERT K et al. High-level nuclear NF-kappa B and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells. Blood 1996; 87: 4340-4347.
38. HINZ M, LOSER P, MATHAS S, KRAPPMANN D, DORKEN B, SCHEIDEREIT C. Constitutive NFkappaB maintains high expression of a characteristic gene network, including CD40, CD86, and a set of antiapoptotic genes in Hodgkin/Reed-Sternberg cells. Blood 200; 97: 2798-2807.
39. MARTIN-SUBERO JI, GESK S, HARDER L, SONOKI T, TUCKER PW, SCHLEGELBERGER B et al. Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma. Blood 2002; 99: 1474-1477.
40. SATTERWHITE E, SONOKI T, WILLIS TG, HARDER L, NOWAK R, ARRIOLA EL et al. The BCL11 gene family: involvement of BCL11A in lymphoid malignancies. Blood 2001; 98: 3413-3420.
41. MARTIN-SUBERO JI, SIEBERT R, HARDER L, GESK S, SCHWINDT P, BRAUNINGER A et al. Cytogenetic and molecular characterization of a patient with simultaneous B-cell chronic lymphocytic leukemia and peripheral T-cell lymphoma. Am J Hematol 2001; 68: 276-279.
42. SPEICHER MR, GWYN BALLARD S, WARD DC. Karyotyping human chromosomes by combinatorial multi-fluor FISH. Nat Genet 1996; 12: 368-375.
43. SCHRÖCK E, DU MANOIR S, VELDMAN T, SCHOELL B, WIENBERG J, FERGUSON-SMITH MA et al. Multicolor spectral karyotyping of human chromosomes. Science 1996; 273: 494-497.
44. CHAGANTI RS, NANJANGUD G, SCHMIDT H, TERUYAFELDSTEIN J. Recurring chromosomal abnormalities in non-Hodgkin's lymphoma: biologic and clinical significance. Semin Hematol 2000; 37: 396-411.
45. The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood 1997; 89: 3909-3918.
46. SCHNEIDER NR, CARROLL AJ, SHUSTER JJ, PULLEN DJ, LINK MP, BOROWITZ MJ et al. New recurrent cytogenetic abnormalities and association of blast cell karyotypes with prognosis in childhood T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group report of 343 cases. Blood 2000; 96: 2543-2549.
47. RABBITTS TH. Chromosomal translocations in human cancer. Nature 1994; 372: 143-149.
48. DREXLER HG, GIGNAC SM, VON WASIELEWSKI R, WERNER M, DIRKS WG. Pathobiology of NPMALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas. Leukemia 2000; 14: 1533-1559.
49. SHIOTA M, NAKAMURA S, ICHINOHASAMA R, ABE M, AKAGI T, TAKESHITA M et al. Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: a distinct clinicopathologic entity. Blood 1995; 86: 1954-1960.
50. FALINI B, PULFORD K, PUCCIARINI A, CARBONE A, DE WOLF-PEETERS C, CORDELL J et al. Lymphomas expressing ALK fusion protein(s) other than NPM-ALK. Blood 1999; 94: 3509-3515.
51. MARTIN-SUBERO JI, CHUDOBA I, HARDER L, GESK S, GROTE W, NOVO FJ et al. Multicolor-FICTION: Expanding the possibilities of combined morphologic, immunophenotypic and genetic single cell analyses. Am J Pathol. (En prensa).
52. SHIPP MA, Ross KN, TAMAYO P, WENG AP, KUTOK JL, AGUIAR RC et al. Diffuse large B-cell lymphoma outcome prediction by geneexpression profiling and supervised machine learning. Nat Med 2002; 8: 68-74.
53. KONONEN J, BUBENDORF L, KALLIONIEMI A, BARLUND M, SCHRAML P, LEIGHTON S et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nature Med 1998; 4: 844-847.